Abdominal MR Imaging at 3.0T: Sequence Optimization and Implementation

July 12, 2023 updated by: University of Nebraska
This project will facilitate the optimization of body MR imaging at 3 Tesla.

Study Overview

Status

Terminated

Intervention / Treatment

Detailed Description

This project is meant to improve the image quality of multiple sequences at 3.0T applied to the abdominal and pelvic regions.

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Nebraska
      • Omaha, Nebraska, United States, 68198
        • University of Nebraska Medical Center
      • Omaha, Nebraska, United States, 68198-1045
        • University of Nebraska Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Subjects between ages of 19 and 65
  • Healthy volunteer subjects should not have any history of disease or symptoms - based on clinical history
  • Subjects with an underlying disorder (diffuse and focal abnormalities of the liver and pancreas)

Exclusion Criteria:

  • Inability to provide informed consent
  • A medical or contraindications that will prevent subjects from having a MRI
  • Subjects with severe renal dysfunction or patients on dialysis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Body MRI healthy volunteers
Body MRI to optimize sequences in healthy individuals and in disorder subjects
Body MR imaging will be performed to optimize sequences
Other Names:
  • Body MR imaging performed to optimize sequences

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Optimizing body MR imaging sequences
Time Frame: 2 years
Healthy volunteers will be used to obtain optimized body MR imaging sequences that will then be used to evaluate MR imaging sequences of subjects with underlying disorders.
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Shahid Hussain, MD, University of Nebraska

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 15, 2009

Primary Completion (Actual)

June 30, 2015

Study Completion (Actual)

June 30, 2015

Study Registration Dates

First Submitted

October 28, 2009

First Submitted That Met QC Criteria

November 3, 2009

First Posted (Estimated)

November 4, 2009

Study Record Updates

Last Update Posted (Actual)

July 14, 2023

Last Update Submitted That Met QC Criteria

July 12, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 0290-09-FB

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diffuse and Focal Abnormalities of the Liver and Pancreas

Clinical Trials on Body MR imaging

Subscribe